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Abstract
Elongation factor-2 (eEF2) catalyzes the movement of the ribosome along the mRNA. A single
histidine residue in eEF2 (H715) is modified to form diphthamide. A role for eEF2 in cellular
stress responses is highlighted by the fact that eEF2 is sensitive to oxidative stress and that it must
be active in order to drive the synthesis of proteins that help cells to mitigate the adverse effects of
oxidative stress. Many of the latter proteins are encoded by mRNAs containing a sequence called
an “internal ribosomal entry site” (IRES). Under high oxidative stress conditions diphthamide-
deficient cells were significantly more sensitive to cell death. These results suggest that
diphthamide may play a role in protection against the degradation of eEF2. Its protection is
especially important under those situations where it is necessary for the re-programming of
translation from global to IRES synthesis. Indeed, we found that the expression of X-linked
inhibitor of apoptosis (XIAP) and fibroblast growth factor 2 (FGF2), two proteins synthesized
from mRNAs with IRES that promote cell survival are deregulated in diphthamide-deficient cells.
Our findings therefore suggest that eEF2/diphthamide controls the selective translation of IRES-
dependent protein targets XIAP and FGF2, critical for cell survival under conditions of oxidative
stress.
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INTRODUCTION
Protein synthesis is an important, complex process that involves RNA and many regulatory
proteins that are influenced by cellular metabolic status and signals from hormones, growth
factors, and nutrient availability [1–3]. This regulatory machinery provides cells with the
plasticity needed to respond to environmental challenges such as oxidative and energetic
stress [4]. The translation process consists of three phases (initiation, elongation and
termination) that each require the participation of several translation factors that transiently
associate with the ribosome. Although the majority of translational control is exerted at the
initiation stage [5], specific regulation of the elongation phase also occurs under certain
conditions [3,6–10].
Two distinctive features of the elongation step are its high energy requirements, and the fact
that it only relies on three factors. Among these factors, elongation factor 2 (eEF2), which
catalyzes the ribosomal movement along the mRNA [3] is a target of several distinct
regulatory signaling pathways. For instance, phosphorylation inactivates eEF2 by preventing
it from binding to the ribosome [11], thereby decreasing the rate of peptide elongation and
contributing to global inhibition of protein synthesis. The phosphorylation of eEF2 is
regulated by nutrients and growth factors which activate mTOR (mammalian target of
rapamycin) resulting in S6 kinase-mediated inhibition of eEF2 kinase, resulting in reduced
phosphorylation of eEF2 and increased protein synthesis [12–14]. Phosphorylation is
particularly important under conditions of an energy deficit, because translation elongation
is a metabolically demanding process. For example, during fasting or exercise AMP kinase
(AMPK) is activated which then phosphorylates eEF2 and thereby inhibits protein synthesis
[15], thereby conserving energy for essential cellular processes that promote cell
maintenance and survival. In addition to the phosphorylation status, eEF2 activity can be
modified through protein-protein interactions. For example, interactions with p53 and
14-3-3 mediate eEF2 nuclear subcellular relocalization in neurons subjected to oxidative
stress [16]. The stress-induced reduction in global translation is usually accompanied by the
selective translation of specific proteins that are required for the cell to withstand the period
of adverse conditions. This process is not dependent on the translation initiation step; instead
the ribosome starts ‘reading’ the mRNA at the Internal Ribosome Entry sequence (IRES)
[17,18]. Although the translation of IRES-mRNA is less dependent on initiation factors, it
still requires elongation factors.
eEF2 can be ribosylated at a unique posttranslational modified derivative of histidine (H715)
known as diphthamide (2-[3-carboxyamido-3-(trimethylammonio)-propyl] histidine).
Diphthamide formation is mediated by the Dph enzymes of which there are five (Dph1 –
Dph5) [19,20]. Diphtheria and cholera toxins catalyze the transfer of ADP-ribose from
NAD+ to the diphthamide imidazole ring (Scheme 1). Neither the identity of the endogenous
ADP-ribosyltransferases that ribosylate eEF2, nor the physiological roles of the diphthamide
are known [19]. However, oxidative stress is known to cause significant changes in ADP-
ribose/NAD metabolism and can increase eEF2 ADP-ribosylation [21].
Because eEF2 is the target of phosphorylation, ribosylation and specific protein-protein
interactions, it is likely that these regulatory mechanisms can function independently or in
conjunction depending on the specific cellular metabolic circumstances. It is possible that
under physiological situations, when the cell respond to nutritional and growth signals,
phosphorylation of eEF2 is sufficient to switch on and off the global protein synthesis.
However, under stress conditions, where ATP is needed for repair process, and eEF2
activity is affected [22–24] other post-translational modifications may play a prominent role.
Argüelles et al. Page 2
Free Radic Biol Med. Author manuscript; available in PMC 2015 February 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
In this paper we investigated the possible role played by eEF2 diphthamide in the cellular
response elicited by oxidative stress. Chinese hamster ovary cells expressing or lacking the
enzyme Dph3 required for the biosynthesis of diphthamide were exposed to increasing
concentrations of cumene hydroperoxide (CH), which induces membrane lipid peroxidation
and affects eEF2 [24,25]. Our results show that eEF-2 diphthamide is important for the
synthesis of X-linked inhibitor of apoptosis (XIAP) and fibroblast growth factor 2 (FGF2),
two proteins encoded by IRES-containing mRNAs and critical for cell survival under
oxidative stress conditions.
MATERIALS AND METHODS
Cell cultures
Wild-type and diphthamide-deficient (Dph3 mutant) Chinese hamster ovary (CHO) cells
were supplied by Stephen H. Leppla (NIAID, NIH), and were grown in α-minimal essential
medium (MEM) supplemented with 8% fetal bovine serum, 25 mM HEPES, 2 mM
glutamine and 50 μg/ml gentamicin.
Cell viability
Cell viability was determined using a MTS assay (Promega, Madison, WI) and a LDH
activity assay (Roche Cytotoxicity detection kit, Mannheim, Germany) according to the
manufacturer’s instructions.
Determination of hydroperoxides using the FOX reagent
The protocol for lipid peroxidation measurements [26] was adapted for a microplate reader.
Forty micrograms of proteins were incubated with 90 μl of H2SO4 for 30 min. Following
addition of 100 μl FOX reagent (0.5 mM ferrous ammonium sulfate, 0.2 mM xylenol orange
and 200 mM sorbitol in 25 mM H2SO4) the mixture was incubated at room temperature for
45 min, protected from light. The formation of ferric ions was detected by measuring the
resulting colored complex with xylenol orange at 540 nm.
Immunoblot analysis
Cell lines were lysed in RIPA buffer (20 mM Tris-HCl, 150mM NaCl, 1 mM EDTA, 1 mM
EGTA, 1% NP-40, 1% sodium deoxycholate, 2.5 mM sodium pyrophosphate and 1 mM
sodium orthovanadate) containing protease inhibitors. The homogenized cells were
centrifuged at 12,000g for 20 min at 4°C. Protein content of the samples was estimated with
Pierce BCA Protein Assay Kit (Pierce Biotechnology, Rockfold, IL). Protein samples were
separated by SDS-PAGE (10% acrylamide), and transferred to a nitrocellulose membrane
(Bio Rad, Hercules, CA) at 120 V for 1 h. The membranes were incubated with blocking
buffer (5% dry milk in 20 mM Tris–HCl, pH 7.5, 500 mM NaCl, 0.05% Tween 20) for 1 h
at room temperature. Membranes were then incubated in blocking solution containing the
following antibodies: eEF2 (1:5000), phospho-eEF-2 and XIAP (1: 1000) (Cell Signaling,
Danvers, MA); FGF-2 (1: 500) (abcam Inc, Cambridge, MA); hnRNP (1:2000) and α-
tubulin (1:1000) (Santa Cruz Biotechnology, Santa Cruz, CA), overnight at 4°C. After
incubation, the membranes were washed in 20 mM Tris–HCl, pH 7.5, 500 mM NaCl, 0.05%
Tween 20 and incubated with peroxidase-conjugated anti-immunoglobulin secondary
antibodies. The proteins were visualized using a chemiluminiscence kit from Pierce
(Rockford, IL). The bands were analyzed by densitometry using Image J analysis software
(NIH).
Argüelles et al. Page 3
Free Radic Biol Med. Author manuscript; available in PMC 2015 February 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
ADP-ribosylation assay
The assay was performed as described previously [27]. Briefly, 50 μg of cell lysates were
incubated in ADP-ribosylation buffer (20 mM Tris-HCl, 1 mM EDTA, 50 Mm DTT; pH
7.4) with 500 ng of FP59 and 5 μM 6-Biotin-17-NAD (Trevigen, Gaithersburg, MD) for 30
min at 37°C. Samples were separated by SDS-PAGE followed by immunoblotting. The
biotin-ADP-ribose-eEF-2 complexes were detected using streptavidin-IR conjugate antibody
(Rockland Immunochemicals, Gilbertsville, PA) and a Typhoon 9400 scanner (GE
Healthcare, Pittsburgh, PA).
Subcellular fractionation
Cells were subfractionated as described previously [28]. Cells were incubated on ice for 10
min in 800 μl of lysis buffer containing 20 mM Tris (pH 7.5), 100 mM KCl, 5 mM MgCl2,
0.3% IGEPAL CA-630 and protease inhibitors. Cells were centrifuged at 1,000 x g for 10
min to separate the cytoplasmic fraction of the cell extract. The nuclei were lysed by
incubation on ice for 45 min with RIPA buffer containing protease inhibitors. The lysate was
then centrifuged at 20,000 g for 20 min. The resulting supernatant was used as the nuclear
fraction of the cell extract. The subcellular fractions were separated by SDS-PAGE and
analyzed by immunoblots using antibodies against cytoplasmic and nuclear marker proteins.
Newly synthesized protein assay
Cells growing in 6-well plates were pretreated with CH, washed with warm PBS, and
incubated in methionine-free D-MEM medium (Invitrogen, Grand Island, NY) for 35 min to
deplete methionine reserves, after which 50 μM L-azidohomoalanine (AHA) (Invitrogen)
was added for 30 min. The cells were lysed and proteins were extracted by ultrasonication in
RIPA buffer containing protease inhibitors. AHA-incorporating proteins were labeled with
tetramethyl rhodamine (TAMRA) using Click-iT Protein Reaction Buffer Kit (Invitrogen).
The TAMRA-labeled proteins in the gel were assayed using a Typhoon 9400scanner (GE
Healthcare).
Immunofluorescence
For immunostaining, cells were plated at a density of 5 × 104 cells/cm2 on 18-mm diameter
round glass coverslips in 12-well plates. After treatment the cells were fixed with 4%
paraformaldehyde, then permeabilized in 0.5% Triton X-100 for 10 min, rinsed with PBS,
and incubated for 1 h with 10% donkey serum. The cells were incubated with the primary
antibodies/antiserum overnight at 4 °C in the blocking solution. The immunocomplexes
were detected using Alexa Fluor 488 (green)-conjugated or Alexa Fluor 546 (red)-
conjugated secondary antibodies (1:1000; 1 h incubation at room temperature). Nuclei were
counterstained with 4′, 6′-diamidino-2-phenylindole (DAPI; Vector Laboratories Inc.,
Burlingame, CA). Image analysis was performed using a Zeiss 510 confocal laser scanning
microscope.
Statistical analysis
Data are shown as the mean ± SEMs. Statistical analysis was performed by one-way
ANOVA, followed by Tukey’s test or by two-way ANOVA using GraphPadPrism Version
5.03 (Graph Pad Software). A p-value of ≤ 0.05 was considered significant.
RESULTS
Effects of CH on lipid peroxidation and cell viability
The inability of eEF-2 to be ADP-ribosylated in diphthamide-deficient (Dph3−) CHO cells
was confirmed using an vitro ADP-ribosylation assay with the cell lysates. (Fig. 1A). To
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investigate the potential role of diphthamide on cell survival in response to oxidative stress,
we analyzed the effect of increasing concentrations of CH on wild-type and Dph3− cells.
Diphthamide-deficient cells were more sensitive to CH such that exposure to 10 and 15 μM
of CH led to a significantly greater decrease in cell viability compared to wild-type cells (12
and 16%, respectively) (Fig. 1B). Similarly, LDH activity after 10 and 15 μM CH treatment
was increased significantly more in Dph3− cells compared to wild-type cells (Fig. 1B).
Lipid peroxidation increased in response to CH, in a concentration-dependent manner, with
no statistically significant differences between wild-type and Dph3− cells (Fig. 1C).
Effects of diphthamide and CH on eEF2 subcellular localization
In order to determine whether diphthamide is involved in the regulation of eEF2 localization
within the cell under basal and stress conditions, the levels of eEF-2 were measured in
whole, cytoplasmic and nuclear fractions of wild-type and Dph3− cells by immunoblot
analysis. The results showed similar levels of eEF2 in the nuclear compartment, but
significantly higher levels of eEF2 in the cytoplasm and whole-cell extract of Dph3− cells
(Fig 2A, B). Immunofluorescences staining confirmed that levels of eEF2 were greater in
Dph3− cells compared to wild-type cells (Fig. 2C).
Next, we analyzed levels of total and translationally inactive (phosphorylated) eEF2 in
cytoplasmic and nuclear extracts from wild-type and Dph3− cells treated with different CH
concentrations. In both cell types the ratio of phosphorylated/total eEF2 was higher in
nuclear extracts. Treatment with CH caused similar increases of both cytoplasmic and
nuclear ratios of phosphorylated to total eEF2 (Fig. 3A, B). Interestingly, the nuclear
phosphorylated/total eEF2 ratio was greater in Dph3− cells compared to wild-type cells. In
wild-type cells, the ratios of phosphorylated to total eEF2 in the nuclear fraction were 3.1-
fold for control, 3.3-fold for 1 μM CH, 3.1-fold for 5 μM CH and 3.9-fold for 10 μM CH
compared to cytoplasm fractions. In the case of Dph3− cells, the ratios in the nuclear
fraction were 4.6-fold for control, 4.7-fold for 1 μM CH, 4.3-fold for 5 μM CH and 4.7-fold
for 10 μM CH.
Diphthamide regulates newly synthesized in response to oxidative stress
We measured levels of newly synthesized proteins in wild-type and Dph3− cells under basal
and oxidative stress conditions. Under basal conditions the rate of newly synthesized
proteins was higher in diphthamide-deficient cells (22%) compared to wild- type cells (Fig.
4A, C). CH treatment produced significant reductions of newly synthesized proteins in both
cell types, with a more pronounced decrease in Dph3− cells; 51% (5 μM CH) and 62% (10
μM CH) compared to Dph3− vehicle-treated cells, and 28% (5 μM CH) and 37% (10 μM
CH) compared to wild-type vehicle-treated cells (Fig. 4D). The levels of total eEF-2
mirrored the changes observed in the newly synthesized proteins assays. eEF2 levels were
higher in diphthamide-deficient cells compared to wild-type cells (17%) (Fig. 5A, B).
However, high lipid peroxidation levels produced a significant decrease of total eEF2 levels
in wild-type cells (10% for 5 μM CH and 19% for 10 μM CH) that was further exacerbated
in Dph3− cells (24% for 5 μM CH and 35% for 10 μM CH) (Fig. 5C). These results suggest
that diphthamide plays a role in eEF2 degradation under normal and oxidative stress
conditions.
Role of Diphthamide on the synthesis of two proteins encoded by IRES-containing mRNAs
(XIAP and FGF2) under oxidative stress conditions
The presence of internal ribosome entry site (IRES) elements located at the 5′-untranslated
regions of specific mRNAs allows synthesis of the encoded proteins during stress conditions
that cause global cap-dependent translation to be halted. We therefore analyzed the levels of
the IRES-dependent protein targets XIAP and FGF2 in wild-type and Dph3− cells under
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basal and oxidative stress conditions (Fig. 6A). XIAP and FGF2 were chosen because they
have previously been shown to promote the survival of cells subjected to oxidative and
metabolic stress [29–32]. In wild-type cells CH-induced lipid peroxidation produced
significant dose-dependent increases of XIAP levels compared to vehicle-treated cells [97%
(C), 143% (1 μM CH), 165% (5 μM CH) and 181% (10 μM CH)]. However, no change with
lower CH concentrations (1 and 5 μM), and a significant decrease in XIAP levels at the
highest CH concentration (10 μM), occurred in Dph3− cells (Fig. 6B).
Next, we measured the levels of FGF2 using an antibody that recognized two isoforms of 18
kDa (isoform 1) and 24 kDa (isoform 2) in extracts from wild-type and Dph3− cells (Fig.
6A). Similarly to what seen for XIAP, a concentration-dependent increase of FGF2 isoform
1 and 2 levels occurred in response to CH treatment in wild-type cells (Fig. 6C, D). On the
other hand, exposure of Dph− cells to CH resulted in little or no change in the levels of
either isoform of FGF2 (Fig. 6C, D). These results suggest that eEF2 diphthamide plays an
important role in regulating the synthesis of XIAP and FGF2 under oxidative stress
conditions.
DISCUSSION
Protein synthesis is a fundamental process that is critical for cellular homeostasis and
responses to stress. Because of its high energy requirements it is tightly regulated, especially
under stress conditions when ATP is diverted toward repair processes. In fact, global
translation is reduced in response to most, if not all, types of cellular stress [4,7,10,33].
However, the stress-induced reduction in global translation is usually accompanied by the
selective translation of specific proteins that are required for the cell to withstand the period
of adverse conditions. This process is not dependent on the translation initiation step; instead
the ribosome starts ‘reading’ the mRNA at the IRES sequence [17,18]. Although IRES-
mediated protein synthesis does not require the initiation factors, it is still dependent on the
elongation factors. Notably, eEF2 is very sensitive to oxidative stress [22–24], and thus its
ability to participate in the IRES synthesis of proteins under adverse oxidative conditions
must depend upon protective regulatory mechanisms.
A unique posttranslational derivative of histidine known as diphthamide is found only in
eEF2. The biological function of diphthamide has not yet been defined. It has been
suggested that diphthamide protects ribosomes against pathogenic ribosome-inactivating
proteins [27]. Furthermore, diphthamide participates in the maintenance of the correct
reading frame during elongation, increasing protein translational accuracy [34]. Less clear
are the effects of diphthamide ribosylation on protein translation. Ribosylation induced by
bacterial toxins results in the cessation of translation [19,35,36]. However other reports
suggest that diphthamide is not strictly required for eEF2 elongation function [27]. Indeed,
diphthamide-deficient cells are viable indicating that eEF2 must retain enough activity to
drive protein synthesis at a rate compatible with cell survival, or that compensatory
mechanisms are induced. Our results showing higher eEF2 cellular content (Fig. 2) and
newly synthesized proteins rate (Fig. 4) in Dph3− cells support the later hypothesis.
Upregulation of eEF2 has been observed in ovarian, gastric and colon cancers [37,38] and it
is believed to be an adaptive mechanism of cancer cells to maintain their high protein
synthesis requirements [1,6]. Modification of diphthamide synthesis genes have also been
linked to cancer susceptibility. Mutations of dph1 (ovac1) gene occur in 90% of ovarian
cancers, as well as other cancer cell types [39]. Given the requirement of diphthamide for
translation accuracy [27], the increased rate of basal newly synthesized proteins is not
necessarily advantageous for the cells under stressful conditions. In fact, our results show
that under high oxidative stress conditions diphthamide-deficient cells exhibited increased
eEF2 degradation (Fig. 5), and were more sensitive to cell death (Fig. 1). These findings
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suggest that eEF2/diphthamide is a critical determinant of the ability of cells to respond to
oxidative stress in ways that promote their survival.
eEF2 is inactivated by phosphorylation resulting in reduction of global protein synthesis.
However, the fact that phosphorylated eEF2 is found in the nucleus of cells and its levels
increase under oxidative stress suggests that this modification may have additional
biological roles. The presence of phosphorylated eEF2 in the nucleus has been associated
with a lower resistance to oxidative stress [16]. Here we showed that diphthamide-deficient
cells have higher levels of total eEF2 in both whole-cell extract and cytoplasm (Fig. 2).
However, eEF2 levels in the nuclear fractions were similar in wild-type and diphthamide-
deficient cells. When the ratio of phosphorylated/total eEF2 was analyzed, this ratio
increased in cytoplasm and to a greater extent in the nucleus in response to oxidative stress.
Whereas the increase in the cytoplasm was similar in both wild-type and Dph3− cells, the
increase in the nucleus was more pronounced in Dph3− cells (Fig 3). These results suggest
that diphthamide plays a role in the subcellular localization of eEF2 under normal and
oxidative stress conditions. In addition to phosphorylation, previous findings indicated that
eEF2 interacts with p53 [16,40]. However, we found that the association between eEF2 and
p53 do not depends on the presence of diphthamide (Results not shown).
Our results suggest that diphthamide plays a role in the protection of cells against the
degradation of eEF2 under normal and oxidative stress conditions. This protection is
especially important under those situations where it is necessary to reduce global protein
synthesis while selectively enabling translation of IRES-containing mRNAs that encode
proteins critical for cell survival. Indeed, we found that the production of two proteins
(XIAP and FGF2) from IRES-containing mRNAs [4,41] is increased in wild-type cells
under oxidative stress conditions. However their expression is deregulated in diphthamide-
deficient cells. This suggests that eEF2/diphthamide can play a relevant role in IRES
translation under oxidative stress.
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Highlights
• Diphthamide regulates global newly synthesized protein during oxidative stress
• Diphthamide plays a role in the protection of cells against the degradation of
eEF2
• eEF2/diphthamide is important to control the translation of IRES-dependent
protein XIAP and FGF2
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Figure 1.
Diphthamide deficiency increases the vulnerability of cells to oxidative stress. A.
Immunoblots for in vitro ADP-ribosylation assay with the cell lysates. The top panel shows
ADP-ribosylated eEF-2 and the bottom panel shows the total eEF-2 in wild-type (WT) or
diphthamide-deficient cells (Dph3−). B. Cells were incubated for 3 h in absence or presence
of the indicated concentrations of CH. Cell viability was measured by the MTS assay and
lactate dehydrogenase (LDH) release assay. Values are the mean and SEM of four
experiments. *p< 0.05 and **p<0.01 (cell viability), †p<0.05 and ††p<0.01 (cell death); WT
versus diphthamide-deficient cells. C. Lipid peroxidation levels were determined using the
FOX method. Values are the mean and SEM of 5 independent experiments. *p< 0.05 and
**p<0.01 versus the wild-type cell control value. †p<0.05 and ††p<0.01 versus the
diphthamide- deficient cell control value.
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Figure 2.
Levels of eEF-2 are elevated in diphthamide-deficient cells. A. Subcellular fractionation and
immunoblot analysis the eEF2 levels. α-tubulin and hnRNP were used as cytoplasmic and
nuclear markers. B. Optical density of the eEF2 bands were normalized to a control (α-
tubulin or hnRNP). Values are the mean and SEM of 4 experiments. ***p< 0.001 versus the
value for whole cell extracts from wild-type cells. †††p<0.001 versus the value for
cytoplasmic extracts from wild-type cells. C. Confocal localization of eEF2 in wild-type and
diphthamide-deficient cells by immunofluorescence (green); nuclei were stained with 4′,6-
diamidino-2-phenylindole (blue). eEF2 integrated intensity (pixel/ μm2): WT 100 ± 5.12%
n=47 cells; Dph3− 136.4 ± 8.3% n=43 cells; t test p=0.00028.
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Figure 3.
The nuclear ratio of phosphorylated to total eEF2 is higher in diphthamide-deficient cells. A
and B. Subcellular fractionation and immunoblot analysis for total and phosphorylated eEF2
were performed on WT cells (A) and diphthamide-deficient cells (B), treated with CH for 3
h. α-tubulin and hnRNP were used as cytoplasmic and nuclear markers, respectively.
Optical density of the eEF2 bands phosphorylated/total in cytoplasm and nucleus were
normalized to a control (α-tubulin or hnRNP). Values are the mean and SEM of 4
experiments. *p<0.05 and ** p<0.01 versus the cytoplasmic control value, †††p<0.001
versus the nuclear control value. ‡‡‡ p<0.001 versus the cytoplasmic control value.
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Figure 4.
Evidence that diphthamide preserves the function of eEF2 in protein synthesis under
conditions of oxidative stress. A and B. To directly determine the effects of CH on newly
synthesized proteins, wild-type cells (WT) and diphthamide-deficient cells (Dph3−) were
pretreated with CH in methionine-free D-MEM containing L-azidohomoalanine (AHA) to
label the newly synthesized proteins. After electrophoresis the gels were analyzed using a
Typhoon 9400 scanner (GE Healthcare) at 545 nm excitation and 580 nm emission (A),
transferred to a nitrocellulose membrane and stained with Ponceau Red (B). C. Newly
synthesized proteins in WT and diphthamide-deficient cells (Dph3−) under control
conditions. Values are the mean and SEM of 4 experiments. **p<0.01 versus the WT
control value. D. Newly synthesized proteins in WT and diphthamide-deficient cells
(Dph3−) treated with CH. Values are the mean and SEM of 4 experiments. ***p<0.001
versus the WT control value. †††p<0.001 versus the diphthamide-deficient cell control
value. ‡‡ p<0.01 versus the WT control value. § p<0.05 versus the WT 1 μM CH value.
Under oxidative stress, eEF2 in diphthamide deficient cells was more affected than in wild-
type cells.
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Figure 5.
Levels of total eEF2 mirror the changes observed in the newly synthesized proteins assays.
To directly determine the effects of CH on eEF2, wild-type cells (WT) and diphthamide-
deficient cells (Dph3−) were pretreated with CH. A. Immunoblot analysis showing eEF-2
levels in the same nitrocellulose membrane depicted in Figure 4A-B. B. Optical density of
the eEF-2 bands under basal conditions. Values are the mean and SEM of 4 experiments.
*p< 0.05 and **p<0.01 vs. WT control. C. Optical density of the eEF2 bands following CH
treatment. Values are the mean and SEM of 4 experiments. *p< 0.05 and ***p<0.001 versus
the WT control value. †††p<0.001 versus the diphthamide-deficient cell control value. ‡‡
p<0.01 versus the WT control value. § p<0.05 versus the WT 1 μM CH value.
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Figure 6.
Evidence for the involvement of eEF2/diphthamide in the control the translation of IRES-
dependent protein XIAP and FGF2. A. The levels of XIAP, FGF2 were detected as
described in the Materials and Methods, and the optical densities were normalized to a
control (α-tubulin). B – D. Optical densities of the XIAP bands (B) and FGF2 isoforms 1
(C) and 2 (D). Values are the mean and SEM of 4 experiments. ***p<0.001 versus the WT
control value. †††p<0.001 versus the diphthamide-deficient cell control value. ††p<0.01
versus the diphthamide-deficient cell control value. †p<0.05 versus the diphthamide-
deficient cell control value. ‡‡‡ p<0.001 versus the WT 1 μM CH value. §§§ p<0.001 versus
the WT 5 μM CH value. ¶¶¶ p<0.001 versus the WT 10 μM CH value.
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Scheme 1.
Diphthamide synthesis (Step 1) and ADP-ribosylation (Step 2). Dph1 to Dph5 are required
for the biosynthesis of diphthamide and are involved in the transfer of a 3-amino-3-
carboxypropyl and a methyl group to histidine 715 of eEF-2. The diphthamide imidazole
ring is the site for nicotinamide adenine dinucleotide (NAD)+ dependent ADP-ribosylation
yielding ADP ribosyl diphthamide.
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